Albemarle Reports Larger-Than-Expected Q4 Loss Amid Lithium Price Weakness
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1h ago
0mins
Should l Buy ALB?
Source: seekingalpha
- Poor Financial Performance: Albemarle reported a net loss of $455.9 million for Q4, translating to a loss of $3.87 per share, a stark decline from a net profit of $33.6 million or $0.29 per share in the same quarter last year, highlighting the operational pressures amid weak battery metal prices.
- Australian Plant Idling: The company has decided to idle the last active train at its Kemerton lithium hydroxide processing plant in Western Australia immediately and has canceled plans for two new trains, which will further impact its lithium production capacity.
- Increasing Market Challenges: Although there have been recent improvements in lithium prices, Albemarle's Chairman and CEO Kent Masters stated that these gains are insufficient to offset the challenges facing Western hard-rock lithium conversion operations, indicating a tough industry environment.
- Core Strategy Unchanged: Despite the decision regarding the Kemerton plant affecting processing capacity, Albemarle's mining interests in Australia, including its co-ownership of the Greenbushes mine with China's Tianqi Lithium and Wodgina, remain core components of the company's strategy and are unaffected.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ALB?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ALB
Wall Street analysts forecast ALB stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ALB is 149.79 USD with a low forecast of 85.00 USD and a high forecast of 210.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
20 Analyst Rating
10 Buy
10 Hold
0 Sell
Moderate Buy
Current: 168.560
Low
85.00
Averages
149.79
High
210.00
Current: 168.560
Low
85.00
Averages
149.79
High
210.00
About ALB
Albemarle Corporation is engaged in transforming essential resources into critical ingredients for mobility, energy, connectivity, and health. The Company’s segments include Energy Storage, Specialties, and Ketjen. The Energy Storage segment develops and manufactures a range of basic lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride. Its Specialties business optimizes its portfolio of bromine and highly specialized lithium solutions. Its Specialties business serves a variety of industries, including energy, mobility, connectivity, and health. Specialty products are essential in both internal combustion and electric vehicles, from high-voltage cables and powertrains to airbags and tires. Its Ketjen segment includes clean fuels technologies (CFT), fluidized catalytic cracking (FCC) catalysts and additives, and performance catalyst solutions (PCS). It serves various markets such as grid storage, automotive, aerospace, conventional energy, and others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Albemarle Reports Larger-Than-Expected Q4 Loss Amid Lithium Price Weakness
- Poor Financial Performance: Albemarle reported a net loss of $455.9 million for Q4, translating to a loss of $3.87 per share, a stark decline from a net profit of $33.6 million or $0.29 per share in the same quarter last year, highlighting the operational pressures amid weak battery metal prices.
- Australian Plant Idling: The company has decided to idle the last active train at its Kemerton lithium hydroxide processing plant in Western Australia immediately and has canceled plans for two new trains, which will further impact its lithium production capacity.
- Increasing Market Challenges: Although there have been recent improvements in lithium prices, Albemarle's Chairman and CEO Kent Masters stated that these gains are insufficient to offset the challenges facing Western hard-rock lithium conversion operations, indicating a tough industry environment.
- Core Strategy Unchanged: Despite the decision regarding the Kemerton plant affecting processing capacity, Albemarle's mining interests in Australia, including its co-ownership of the Greenbushes mine with China's Tianqi Lithium and Wodgina, remain core components of the company's strategy and are unaffected.
See More
Albemarle Q4 2025 Earnings Report Analysis
- Earnings Performance: Albemarle reported a Q4 2025 non-GAAP EPS of -$0.53, missing expectations by $0.04, indicating challenges in profitability that could impact investor confidence.
- Revenue Beat: Despite the EPS miss, Albemarle's revenue reached $1.43 billion, exceeding market expectations by $80 million, suggesting strong sales in the lithium market that may lay the groundwork for future growth.
- Market Reaction: The stock price may react negatively due to the earnings miss, prompting investors to closely monitor subsequent market dynamics and potential strategic adjustments by the company.
- Future Outlook: Although the current earnings report shows some pressure, Albemarle's long-term prospects in the lithium industry remain positive, particularly with the ongoing demand growth in electric vehicles and renewable energy sectors.
See More
Albemarle Q4 Earnings Beat Expectations Despite EPS Miss
- Significant Revenue Growth: Albemarle reported Q4 revenue of $1.43 billion, a 16.3% year-over-year increase that exceeded market expectations by $80 million, indicating strong demand and sales capabilities in the lithium market.
- Net Sales Performance: The fourth quarter net sales reached $1.4 billion, up 16% year-over-year, with the Energy Storage segment growing by 17% and Ketjen by 13%, demonstrating robust growth across all business segments.
- Optimistic Future Outlook: The company forecasts FY 2026 revenue of $6.00 billion and a non-GAAP EPS of $2.61, reflecting sustained demand for lithium products and Albemarle's leadership position in the sector.
- Market Reaction: Despite the revenue beat, Albemarle's stock fell by 1.6%, likely due to the EPS miss, highlighting investor concerns regarding profitability.
See More
Albemarle Reports $414.2 Million Net Loss in Q4
- Financial Decline: Albemarle Corporation reported a net loss of $414.2 million in Q4, translating to a loss of $3.87 per share, contrasting sharply with a net income of $75.3 million or $0.29 per share last year, indicating significant financial distress.
- Adjusted Loss Improvement: The adjusted loss per share improved to $0.53 from $1.09 in the previous year, suggesting some progress in cost control and operational efficiency despite the overall loss.
- Sales Revenue Growth: The company achieved net sales of $1.428 billion in the fourth quarter, an 8% increase from $1.232 billion last year, reflecting a resilient sales performance despite the financial challenges.
- Operational Adjustment Plan: Albemarle has decided to idle Train 1 at its Kemerton lithium hydroxide processing plant in Western Australia, effective immediately, with this decision expected to positively impact adjusted EBITDA starting in Q2 2026, ensuring future lithium hydroxide supply.
See More
Albemarle Reports Q4 2025 Results with Significant Sales Growth
- Significant Sales Growth: Albemarle's Q4 2025 net sales reached $1.428 billion, reflecting a 15.9% year-over-year increase, primarily driven by strong performance in Energy Storage and Ketjen, indicating robust execution amid dynamic market conditions.
- Widening Net Loss: The company reported a net loss of $414.2 million in Q4, an increase of $490 million year-over-year, largely due to tax-related items and asset write-downs, highlighting challenges in asset management and financial flexibility.
- Improved Adjusted EBITDA: Despite the losses, Albemarle's adjusted EBITDA stood at $268.7 million, up 7.2% from the previous year, primarily due to price increases in Energy Storage and productivity improvements, demonstrating effective cost control measures.
- Cautious Future Outlook: The company anticipates flat overall sales in 2026, constrained by fluctuations in lithium market prices and demand changes, particularly in the automotive and construction sectors, which may impact long-term growth potential.
See More
Albemarle Idles Lithium Hydroxide Production at Kemerton Plant
- Operational Suspension Decision: Albemarle has announced the immediate idling of Train 1 at its Kemerton lithium hydroxide processing plant in Western Australia to enhance financial flexibility and preserve optionality, as recent lithium price improvements are insufficient to offset the challenges facing Western hard-rock lithium conversion operations.
- Production Capacity Adjustment: This decision follows the idling of Train 2 in 2024 and the cessation of expansion plans for Trains 3 and 4, indicating the company's proactive measures to reduce operating costs after two and a half years of price volatility in the market.
- Expected Financial Impact: The decision is anticipated to positively affect adjusted EBITDA starting in the second quarter of 2026, with no impact on projected 2026 volumes, demonstrating the company's strong capability to meet customer demand despite operational changes.
- Core Strategy Unchanged: Albemarle's mining interests in Australia, including holdings in Greenbushes and Wodgina, remain core components of the company's strategy, ensuring long-term stability amid market fluctuations in lithium prices.
See More
Albemarle Reports Larger-Than-Expected Q4 Loss Amid Lithium Price Weakness
- Poor Financial Performance: Albemarle reported a net loss of $455.9 million for Q4, translating to a loss of $3.87 per share, a stark decline from a net profit of $33.6 million or $0.29 per share in the same quarter last year, highlighting the operational pressures amid weak battery metal prices.
- Australian Plant Idling: The company has decided to idle the last active train at its Kemerton lithium hydroxide processing plant in Western Australia immediately and has canceled plans for two new trains, which will further impact its lithium production capacity.
- Increasing Market Challenges: Although there have been recent improvements in lithium prices, Albemarle's Chairman and CEO Kent Masters stated that these gains are insufficient to offset the challenges facing Western hard-rock lithium conversion operations, indicating a tough industry environment.
- Core Strategy Unchanged: Despite the decision regarding the Kemerton plant affecting processing capacity, Albemarle's mining interests in Australia, including its co-ownership of the Greenbushes mine with China's Tianqi Lithium and Wodgina, remain core components of the company's strategy and are unaffected.
See More
Albemarle Q4 2025 Earnings Report Analysis
- Earnings Performance: Albemarle reported a Q4 2025 non-GAAP EPS of -$0.53, missing expectations by $0.04, indicating challenges in profitability that could impact investor confidence.
- Revenue Beat: Despite the EPS miss, Albemarle's revenue reached $1.43 billion, exceeding market expectations by $80 million, suggesting strong sales in the lithium market that may lay the groundwork for future growth.
- Market Reaction: The stock price may react negatively due to the earnings miss, prompting investors to closely monitor subsequent market dynamics and potential strategic adjustments by the company.
- Future Outlook: Although the current earnings report shows some pressure, Albemarle's long-term prospects in the lithium industry remain positive, particularly with the ongoing demand growth in electric vehicles and renewable energy sectors.
See More
Albemarle Q4 Earnings Beat Expectations Despite EPS Miss
- Significant Revenue Growth: Albemarle reported Q4 revenue of $1.43 billion, a 16.3% year-over-year increase that exceeded market expectations by $80 million, indicating strong demand and sales capabilities in the lithium market.
- Net Sales Performance: The fourth quarter net sales reached $1.4 billion, up 16% year-over-year, with the Energy Storage segment growing by 17% and Ketjen by 13%, demonstrating robust growth across all business segments.
- Optimistic Future Outlook: The company forecasts FY 2026 revenue of $6.00 billion and a non-GAAP EPS of $2.61, reflecting sustained demand for lithium products and Albemarle's leadership position in the sector.
- Market Reaction: Despite the revenue beat, Albemarle's stock fell by 1.6%, likely due to the EPS miss, highlighting investor concerns regarding profitability.
See More
Albemarle Reports $414.2 Million Net Loss in Q4
- Financial Decline: Albemarle Corporation reported a net loss of $414.2 million in Q4, translating to a loss of $3.87 per share, contrasting sharply with a net income of $75.3 million or $0.29 per share last year, indicating significant financial distress.
- Adjusted Loss Improvement: The adjusted loss per share improved to $0.53 from $1.09 in the previous year, suggesting some progress in cost control and operational efficiency despite the overall loss.
- Sales Revenue Growth: The company achieved net sales of $1.428 billion in the fourth quarter, an 8% increase from $1.232 billion last year, reflecting a resilient sales performance despite the financial challenges.
- Operational Adjustment Plan: Albemarle has decided to idle Train 1 at its Kemerton lithium hydroxide processing plant in Western Australia, effective immediately, with this decision expected to positively impact adjusted EBITDA starting in Q2 2026, ensuring future lithium hydroxide supply.
See More
Albemarle Reports Q4 2025 Results with Significant Sales Growth
- Significant Sales Growth: Albemarle's Q4 2025 net sales reached $1.428 billion, reflecting a 15.9% year-over-year increase, primarily driven by strong performance in Energy Storage and Ketjen, indicating robust execution amid dynamic market conditions.
- Widening Net Loss: The company reported a net loss of $414.2 million in Q4, an increase of $490 million year-over-year, largely due to tax-related items and asset write-downs, highlighting challenges in asset management and financial flexibility.
- Improved Adjusted EBITDA: Despite the losses, Albemarle's adjusted EBITDA stood at $268.7 million, up 7.2% from the previous year, primarily due to price increases in Energy Storage and productivity improvements, demonstrating effective cost control measures.
- Cautious Future Outlook: The company anticipates flat overall sales in 2026, constrained by fluctuations in lithium market prices and demand changes, particularly in the automotive and construction sectors, which may impact long-term growth potential.
See More
Albemarle Idles Lithium Hydroxide Production at Kemerton Plant
- Operational Suspension Decision: Albemarle has announced the immediate idling of Train 1 at its Kemerton lithium hydroxide processing plant in Western Australia to enhance financial flexibility and preserve optionality, as recent lithium price improvements are insufficient to offset the challenges facing Western hard-rock lithium conversion operations.
- Production Capacity Adjustment: This decision follows the idling of Train 2 in 2024 and the cessation of expansion plans for Trains 3 and 4, indicating the company's proactive measures to reduce operating costs after two and a half years of price volatility in the market.
- Expected Financial Impact: The decision is anticipated to positively affect adjusted EBITDA starting in the second quarter of 2026, with no impact on projected 2026 volumes, demonstrating the company's strong capability to meet customer demand despite operational changes.
- Core Strategy Unchanged: Albemarle's mining interests in Australia, including holdings in Greenbushes and Wodgina, remain core components of the company's strategy, ensuring long-term stability amid market fluctuations in lithium prices.
See More
